Myrlynn Delille, MD
Interventional Pain Medicine · Acworth, GANPI 1932337599
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,676 of the $6,534 with a category attached, or 71.6%. 32 manufacturers reported payments, led by Nevro Corp. at 36.8% of the total. Reporting peaked in 2019 at $3,598 and has fallen 75.2% since, to $891 in 2025.
Across 190 payments — averaging $34.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Boston Scientific$932
- Stryker$827
- Abbott$372
- Scilex Pharmaceuticals Inc.$253
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$251
- plus $1K from 26 others
What the payments were for
- Travel & lodging$1,83328%
- Food & beverage$4,67672%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 32 | $2,404 |
| Boston Scientific | 13 | $932 |
| Stryker | 2 | $827 |
| Abbott | 12 | $372 |
| Scilex Pharmaceuticals Inc. | 12 | $253 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $251 |
| Assertio Therapeutics, Inc. | 10 | $184 |
| Zyla Life Sciences, Inc. | 13 | $152 |
| Arbor Pharmaceuticals, Inc. | 9 | $137 |
| Amgen(2 entities) | 9 | $131 |
| Pfizer | 8 | $121 |
| Pacira Therapeutics, Inc. | 9 | $121 |
| Daiichi Sankyo Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Sentynl Therapeutics, Inc. | 4 | $56 |
| Kaleo, Inc. | 4 | $55 |
| Azurity Pharmaceuticals, Inc. | 2 | $44 |
| AbbVie | 2 | $42 |
| Vertical Pharmaceuticals, LLC | 3 | $41 |
| MDD US Operations, LLC | 2 | $39 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Medtronic | 1 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Shionogi Inc | 1 | $18 |
| Globus Medical | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $14 |
| Vertiflex, Inc. | 1 | $13 |
| Merit Medical Systems Inc | 1 | $9 |
| Curonix LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,534 in reported general payments places this provider in the 60th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 365 | $10,872 |
| Gabapentin | 442 | $6,475 |
| MovantikNaloxegol Oxalate | 13 | $5,386 |
| Duloxetine Hcl | 223 | $4,159 |
| Diclofenac Sodium | 47 | $1,909 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,030 |
| Baclofen | 59 | $706 |
| Tramadol Hcl | 46 | $535 |
| Methocarbamol | 54 | $502 |
| Ibuprofen | 37 | $447 |
| Celecoxib | 36 | $423 |
| Methylprednisolone | 56 | $320 |
| Tizanidine Hcl | 44 | $274 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $203 |
| Methadone Hcl | 13 | $202 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Acworth
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
- Christopher AndrianoStockbridge$41K
- Guensley DelvaWaycross$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.